Biological and Environmental Sampling at ATSDR PFAS Exposure Assessment Sites
On this page:
BACKGROUND AND AIM
The Agency for Toxic Substances and Disease Registry (ATSDR) conducted biomonitoring exposure assessments (EAs) in communities near U.S. military installations that have documented exposures to PFAS in drinking water. Drinking water concentrations of PFAS were mitigated prior to initiation of the biomonitoring efforts.
METHODSEAs were conducted in ten communities using a community sampling design to determine the distribution of PFAS serum concentrations in communities with recent or past exposure to PFAS in drinking water. PFAS urine concentrations were measured in a subset of participants and PFAS concentrations in indoor dust and tap water were collected from a subset of participating households. All participants completed a questionnaire to gather information to characterize each person’s exposure. Responses to the exposure history questionnaire were evaluated to identify demographic and exposure characteristics associated with PFAS levels in serum.
RESULTSThe results of the EA in two locations, Hampden County Massachusetts and New Castle Delaware, will be presented. The primary PFAS elevated in serum included PFHxS, PFOS and PFOA, which were associated with drinking water exposure. PFHxS was the most elevated PFAS in serum with levels being 9.8 times higher than the National Health and Nutrition Examination Survey (NHANES) national average level in Delaware and 4 times higher in Massachusetts. Males had higher PFAS serum levels than females at both locations; additional site-specific findings regarding serum levels and demographic and exposure characteristics information will be presented. Dust sampling results indicated that non-drinking water sources of PFAS may also contribute to exposure.
CONCLUSIONS
The relationships between historical maximum concentrations of PFAS measured in drinking water supplies at the sites and concentrations of PFAS measured in serum will be presented. Additional environmental sampling is being conducted in partnership with U.S. EPA in Delaware and Massachusetts to evaluate potential non-drinking water exposures to PFAS.